TECHNOLOGY

VetVision DXC Product Pipeline

Transforming veterinary care through precision evidence based on microRNAs.
Our VetVision DXC pipeline represents a range of multi-species diagnostics designed to provide veterinarians with predictive insights across various areas of animal health.

MMVD-VetVision DXC

Our flagship test for myxomatous mitral valve disease (MMVD) in dogs, the most common cardiac condition in this species. Launch: Q4 2025.

Dairy Cow Welfare

An innovative microRNA-based test to assess the welfare of dairy cows through milk sample analysis, contributing to healthier herds and sustainable farming.

Oncology Panel

A diagnostic panel for canine mast cell tumors, as well as broad cancer screening in dogs and cats, enabling early detection of a wide range of cancers.

Equine Health

Pipeline projects focused on equine health, including tests for the early detection of pain and respiratory conditions, as well as the monitoring of gastric ulcers in horses.